The Cost of Integrated HIV Care and Buprenorphine/ Naloxone Treatment: Results of a Cross-Site Evaluation

BACKGROUND: Implementing integrated HIV and buprenorphine/ naloxone treatment requires cost estimates to plan and obtain funding. METHODS: We identified costs incurred at HIV clinical sites participating in a cross-site evaluation of integrated care that followed patients for 1 year. Costs include l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Schackman, Bruce R., Leff, Jared A., Botsko, Michael, Fiellin, David A., Altice, Fredrick L., Korthuis, P. Todd, Sohler, Nancy, Weiss, Linda, Egan, James E., Netherland, Julie, Gass, Jonathan, Finkelstein, Ruth
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3270565/
https://ncbi.nlm.nih.gov/pubmed/21317599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31820a9a66
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares